Table 3. Uni/Multivariate analysis of CDK4/6SA in combination with Ki-67 in low-risk patients.
Univariate analysis |
Multivariate analysis |
||||||
---|---|---|---|---|---|---|---|
Parameter | Criteria | HR | 95% CI | P-value | HR | 95% CI | P-value |
Age | >60 | 2.00 | 0.150–8.85 | 0.336 | |||
⩽60 | |||||||
Stage | ⩽II | 3.40 | 0.414–28.1 | 0.256 | |||
⩾III | |||||||
Vascular invasion | No | 3.00 | 0.583–15.2 | 0.192 | 1.59 | 0.248–10.2 | 0.628 |
Yes | |||||||
Histological grade | I | 2.30 | 0.209–10.0 | 0.287 | |||
II and III | |||||||
Tumour size | <5 cm | 2.70 | 0.618–12.2 | 0.187 | 2.86 | 0.508–16.1 | 0.236 |
⩾5 cm | |||||||
Myometrial invasion | ⩽1/2 | 0.90 | 0.167–4.36 | 0.849 | |||
>1/2 | |||||||
Lymphatic invasion | No | 1.50 | 0.180–12.2 | 0.716 | |||
Yes | |||||||
CDK4-IHC | <1.5 | 1.60 | 0.624–4.12 | 0.328 | |||
⩾1.5 | |||||||
CDK4/6SA and Ki-67 | High and high | 11.80 | 1.44–97.3 | 0.022 | 11.39 | 1.23–105 | 0.033 |
Others |
Abbreviations: CDK4=cyclin-dependent kinase 4; CDK4/6SA=CDK4/6-specific activity; IHC=immunohistochemistry. Bold entries denote HR>10 or P<0.2 (significant). Italic entries indicate P<0.05 (significant).